Search Results980 results found
Why CSL Behring’s Diane McCabe has organ donation in her thoughts at work and at home.
CSL Behring, Leader in Rare Diseases, Hosts a Symposium on CIDP, Presents 7 Poster Sessions Featuring PATH Study Data at the 15th International Congress on Neuromuscular Diseases
CSL Behring hosts symposium featuring patient perspective on subcutaneous immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) treatment
CSL Behring Presents New Data on Subcutaneous Immunoglobulin Treatment from the Largest CIDP Study, the PATH Trial, at the 4th Congress of the European Academy of Neurology
CSL Behring offers a portfolio of immunoglobulin therapies to address the unique needs of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) patients
My Access Offers Out-of-Pocket Payment Assistance to Eligible People in the United States Who Are Treating Hemophilia A or von Willebrand Disease with a CSL Behring Therapy
CSL Behring is a global biotech company leading the way to deliver innovative therapies for rare and serious diseases.
During a pandemic, the global biotech organization hires Dr. Michelle McMurry-Heath to tell the story of science.
CSL Behring Recognized for its Longstanding Commitment to Delivering Innovative Products and Programs that Advance the Care of the Bleeding Disorders Community
A year-long lab assignment helps a young researcher find her path
Here’s why thousands of biotech leaders flock to the global meetup